Skip to main content

Table 8 Effects of Artemether and Lumefantrine loaded LSES on SRBC induced delayed-type hypersensitivity and haemagglutination titre in mice

From: Solubility enhancing lipid-based vehicles for artemether and lumefantrine destined for the possible treatment of induced malaria and inflammation: in vitro and in vivo evaluations

Treatment groups

HA

DTH response (mm)

Group 1

96 ± 18.47

0.80 ± 0.06

Group 2

6 ± 1.15

0.15 ± 0.03

Group 3

50 ± 26.61

0.70 ± 0.22

Group 4

32 ± 11.31

0.40 ± 0.11

Group 5

20 ± 6.93

0.35 ± 0.06

Group 6

26 ± 6.00

0.38 ± 0.06

Group 7

42 ± 13.61

0.43 ± 0.11

Group 8

34 ± 11.49

0.40 ± 0.08

Group 9

44 ± 28.56

0.50 ± 0.14